icon-folder.gif   Conference Reports for NATAP  
 
  IDWeek
October 3 -7, 2018
San Francisco, CA
Back grey_arrow_rt.gif
 
 
 
A RETROSPECTIVE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF A NUCLEOSIDE-SPARING REGIMEN OF DARUNAVIR, RITONAVIR AND DOLUTEGRAVIR
 
 
  Reported by Jules Levin
IDWeek Oct 3-7 SF 2018
 
John Verna, PA-C, AAHIVS, Stephen Austin, MS

1010181

1010182

1010183

1010184